“…In addition to Σ PCBs, we also assessed interaction by the sum of 12 PCB congeners with anti-estrogenic/dioxin-like properties (i.e., IUPAC #s 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169 and 189 (Cooke et al, 2001, Van den Berg et al, 2006, Wolff et al, 1997)), the sum of seven PCB congeners with estrogenic properties in vivo or in vitro (i.e., IUPAC #s 52, 77, 95, 99, 101, 110 and 153 (Cooke et al, 2001)), the sum of thyroid active congeners likely to compete for binding to serum TBPs (i.e., IUPAC #s 28, 52, 60, 74, 77, 95, 99, 101, 105, 114, 118, and 126 (Bloom et al, 2014; Chauhan et al, 2000)), and the sum of non-dioxin-like/ortho- PCB congeners that may inhibit dopamine transporter (i.e., IUPAC #s 28, 52, 74, 99, 101, 110, 118, 138, 153, and 180 (Wigestrand et al, 2013)). We reported individual and joint effects for models with p-value (p) < significant product terms (Knol et al, 2009).…”